Cross Country Healthcare stock holds steady as Q2 2026 figures frame valuation

Published on 09/02/2026 at 22:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cross Country Healthcare stock is trading sideways around its latest quote, while investors weigh Q2 2026 revenue and earnings trends in the broader healthcare staffing sector.

CCRN, US2274901000, Illustration mit AI erstellt.

Cross Country Healthcare stock (ISIN US2274901000) is indicated at 13.25 US dollars as of September 2, 2026, giving the staffing specialist a market capitalization of 428.061 million US dollars according to market data from Yahoo Finance. The latest quote shows the share unchanged at 0.00% on this snapshot, leaving investors focused more on fundamentals and sector dynamics than on intraday price moves. In the DACH region, healthcare staffing peers such as AMN Healthcare Services are also tracked by German investors as part of the wider medical care facilities segment.

Recent price level and market context

According to a stock overview on Yahoo Finance that lists Cross Country Healthcare alongside other healthcare names, the CCRN quote stands at 13.25 US dollars with a market capitalization of 428.061 million US dollars as of September 2, 2026. The same overview classifies the company within the medical care facilities industry, highlighting its role in providing workforce solutions to hospitals and clinics. For investors, this price level serves as a reference point for comparing CCRN to larger healthcare players that often trade at significantly higher market caps.

The interactive chart and quote summary show Cross Country Healthcare next to AMN Healthcare Services and other U.S. healthcare stocks, underlining that both companies operate in related segments of nurse and physician staffing. While the CCRN quote in the snapshot is flat at 0.00%, the broader healthcare services space has recently seen double-digit moves when companies deliver strong quarterly numbers. This contrast between a stable CCRN quote and more volatile peers invites an examination of fundamentals and growth prospects rather than short-term price swings.

Fundamentals and earnings signals in the sector

In the absence of a fresh earnings release from Cross Country Healthcare on September 2, 2026, investors often look at the most recent reported figures in the sector to gauge demand for healthcare staffing. A note on the AMN Healthcare Services page indicates that AMN has delivered strong Q2 calendar 2026 numbers, with its stock jumping 11.5% after the announcement according to a StockStory news summary linked from a TradingView chart. This reaction underscores how revenue and earnings beats in healthcare staffing can translate directly into price moves when demand for clinicians is robust.

Across the broader healthcare landscape, revenue and profit trends offer additional context. A research report on GE HealthCare highlights that in Q2 calendar 2026, GE HealthCare generated revenue of 5.30 billion US dollars, beating analyst estimates of 5.27 billion US dollars with year on year growth of 5.8%. The same report notes adjusted earnings per share of 1.44 US dollars, around 3% above consensus, illustrating how modest top line outperformance combined with better margins can still support a positive share-price reaction. While these figures belong to a diversified equipment and services provider rather than a pure staffing firm, they show that healthcare demand remains solid.

Another earnings example from the pharmaceutical space comes from Merck, where a detailed Tender Alpha analysis reports that Q2 2026 sales rose 5% to 16.61 billion US dollars compared with 15.81 billion US dollars in Q2 2025. This 5% increase in quarterly sales, though in a different healthcare sub-sector, signals that overall healthcare spending continues to grow, which can indirectly support staffing providers like Cross Country Healthcare as hospitals expand services and require more clinical personnel.

Operational backdrop: demand for nurses and clinicians

The operational environment for Cross Country Healthcare is shaped by ongoing demand for travel nurses and other specialized clinicians. Job postings for intensive care unit registered nurses in large metropolitan areas such as New York City show weekly pay levels that reflect constrained supply. One travel nursing portal states that as of September 1, 2026, the average weekly pay for an intensive care unit RN in New York City was 2,478 US dollars, with a range between 2,414 and 2,541 US dollars per week. This compensation level indicates strong demand for critical care skills and supports the economic rationale for healthcare staffing companies that match clinicians with hospitals and health systems.

Similarly, healthcare systems recruiting nurse supervisors and advanced practice clinicians continue to emphasize certifications such as CCRN and advanced life support credentials, pointing to sustained complexity in patient care. For workforce solution providers like Cross Country Healthcare, such trends suggest that hospitals will keep relying on external staffing partners to fill shifts, especially in high acuity units. This operational backdrop contributes to the long-term demand story behind CCRN stock, even when the share price itself is not moving sharply on a given day.

Representative service offering

Cross Country Healthcare focuses on healthcare staffing services, including travel nurse assignments, allied health professionals and physician locum tenens placements. These services generate revenue when hospitals and clinics contract the company to provide personnel for fixed-term assignments that supplement their own staff. In practical terms, Cross Country Healthcare may place an intensive care unit nurse at a New York City hospital on a 13 week contract where the nurse earns around the 2,478 US dollars weekly average reported for September 1, 2026, while the company bills the hospital at a higher rate that covers compensation, benefits and its margin.

Stock and investor perspective

For investors tracking Cross Country Healthcare stock, the latest available quote of 13.25 US dollars as of September 2, 2026 and the associated market capitalization of 428.061 million US dollars frame the current valuation relative to other healthcare names listed on Nasdaq. The share in this snapshot is flat on the day at 0.00%, suggesting that the market is waiting for the next catalyst, such as upcoming earnings or new contracts in the healthcare staffing segment. Until then, sector comparisons, revenue growth signals from broader healthcare companies and visible demand for specialized nurses and clinicians provide the main reference points for assessing CCRN within a diversified portfolio.